Aviral Vatsa
A
thread 1/5
1/5 🧪 New breakthrough in #CancerResearch ! A small molecule AOH1996 has been identified to target a major source of endogenous DNA double-strand breaks, a common cause of cancer. It is claimed that it will revolutionize the therapeutic landscape of cancer treatments.🔬
07:19 PM - Aug 05, 2023
Avatar Avatar Avatar
0
11
45
Aviral Vatsa
A
thread 2/5
2/5 AOH1996 disrupts the activities of Proliferating Cell Nuclear Antigen (PCNA), a key player in DNA replication & repair, causing DNA damage in cancer cells and inhibiting their growth. It's like throwing a wrench into the machinery of cancer cell division!⚙️
07:20 PM - Aug 05, 2023
1
7
Aviral Vatsa
A
thread 3/5
3/5 What's more, AOH1996 has been shown to selectively kill cancer cells, leaving healthy cells intact. This could mean a reduction in the adverse side effects often seen in current cancer treatments. It can be a very tactical attack on the cancer cells!💥
07:20 PM - Aug 05, 2023
1
7
Aviral Vatsa
A
thread 4/5
4/5 Even better, AOH1996 can be orally administered and shows promising metabolic stability, making it a convenient & effective treatment option. Preliminary studies show it suppresses tumor growth both as a standalone treatment & when combined with other therapies.🎯
07:21 PM - Aug 05, 2023
1
6
Aviral Vatsa
A
thread 5/5
5/5 It's early days yet with AOH1996 entering Phase I clinical trials. However, the potential of this new tool in our fight against cancer is exciting. Hopefully, this breakthrough takes us one step closer to winning the war against cancer.🤞 . It is high time really. #cancertreatment
07:22 PM - Aug 05, 2023
3
15
Aviral Vatsa
A
sorry to hear that. This drug is a hope, but yet to go through human trials. So far so good though. research is painfully slow otherwise :( .
In response to Christine.
07:49 PM - Aug 05, 2023
1
2
Christine
A
In response to Aviral Vatsa.
It's good that it is slow. It will help catch errors.
08:30 PM - Aug 05, 2023
0
0

 

{{ notificationModalContent }} {{ promptModalMessage }}